Expert comment: International Clinical Trials Day - University of the Sunshine Coast, Queensland, Australia

Accessibility links

USC News

Expert comment: International Clinical Trials Day

17 May 2019

Experts from the University of the Sunshine Coast Clinical Trials Centre are available to comment ahead of International Clinical Trials Day on Monday 20 May.

Current clinical trials being managed by the USC Clinical Trials team include; cardiovascular disease, cold agglutin disease, common cold, crohn’s disease, viral respiratory illness, heart failure, cytomegalovirus vaccine and paediatric flu vaccine.

A clinical trial is a research study performed by experts from the medical field. It aims to determine if a new drug, diet, or a medical treatment device is safe and effective for the use.

The following experts are available for comment:

Lucas Litewka, Director USC Clinical Trials Centre: 07 5456 5265 or

Dr Nova Evans, Clinical Trial Doctor USC Clinical Trials Centre:

Background on the USC Clinical Trials Centre:

The University of the Sunshine Coast has established the USC Clinical Trials Centre, a world-class, purpose-built clinical trials centre at Sippy Downs and at Morayfield.

The centre is built on a clinical framework that gives industry unprecedented access to a network of private doctors and their patients on the Sunshine Coast and Moreton Bay.

Since operations began in 2016, the centre continues to increase the region’s clinical research capacity and deliver innovative and regionally relevant research in consultation with key stakeholders including local private healthcare professionals, the community, the biopharmaceutical industry and other key thought leaders.

Related articles

Clinical trial of new treatment for lymphoedema
24 Mar 2021

USC Clinical Trials will soon start a clinical trial for an investigational new medication to treat lymphoedema in patients who have previously had breast cancer.

Clinical trial of new treatment for acute myeloid leukaemia
7 May 2021

USC Clinical Trials will soon start a clinical trial to determine the safety and effectiveness of investigational medications to treat acute myeloid leukaemia in patients who have relapsed or are not responsive to standard treatment options.

Clinical trial of needle-free vaccine delivery technology
26 May 2021

USC Clinical Trials is about to begin a study in collaboration with Australian biotechnology company Vaxxas, developers of a potential new needle-free vaccine delivery technology – the high-density microarray patch (HD-MAP).

Contact the USC media team

Name Position Email Phone
Terry Walsh Manager, Media and Messaging +61 7 5430 1160
Clare McKay Media Relations Officer (Regional) +61 7 5456 5669

Search results for

Recent news